NEW YORK, Aug. 23, 2017 /PRNewswire/ -- A California woman has been awarded $417 million, after a jury hearing evidence in the state's first talcum powder lawsuit trial found Johnson & Johnson liable for failing to warn of the possible association between genital talc use and ovarian cancer. The verdict, which included $68 million in compensatory damages and $340 million in punitive damages, is the largest awarded so far in a case involving Johnson & Johnson talcum powders and the often-deadly disease. (Case No. BC628228, Los Angeles County Superior Court)
"This case is especially tragic, as the plaintiff's cancer has reached a terminal stage and she was too ill to be present for the verdict. While no amount of money can make up for her suffering, we believe that this jury has sent a clear message to Johnson & Johnson that its conduct in regards to talc and ovarian cancer was unacceptable," says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective medical devices, drugs and consumer products. The Firm is offering free legal reviews to women who were diagnosed with ovarian cancer that may be associated with Johnson & Johnson's talc-based powders.
Nationwide Talcum Powder Litigation
Johnson & Johnson has been named a defendant in more than 5,000 talcum powder lawsuits currently pending in courts around the country, all of which were filed on behalf of women who allegedly developed ovarian cancer following the regular and repeated use of the company's talc-based powders for feminine hygiene purposes. The lawsuit selected for California's first talc-ovarian cancer trial involved a 63-year-old woman who had used Johnson & Johnson's Baby Powder and Shower-to-Shower talc-based powders for daily feminine hygiene since the age of 11. She was diagnosed with ovarian cancer in 2007.
During the trial in Los Angeles Superior Court, her attorneys highlighted several studies published since the 1970s that suggest an association between long-term genital talc use and an increase risk of ovarian cancer. Jurors were also presented with internal Johnson & Johnson documents that suggested the company was aware of this potential link for at least 30 years, but failed to warn consumers in order to protect the profits from its Baby Powder and Shower-to-Shower franchises.
The California trial was the first convened outside of Missouri's 22nd Circuit Court in St. Louis, where one of the nation's largest talcum powder litigations is currently underway. So far, only one Missouri jury has returned a verdict for Johnson & Johnson. Plaintiffs in four talcum powder lawsuits have been awarded compensatory and punitive damages amounting to $110 million, $70 million, $72 million and $55 million. (Case No. 1422-CC09326-01)
Women who were diagnosed with ovarian cancer following the long-term use of talc-based powder for feminine hygiene purposes may be eligible to file their own talcum powder lawsuit. To learn more, please visit Bernstein Liebhard LLP's website, or call 800-511-5092 to arrange for a free, no obligation case review.
About Bernstein Liebhard LLP Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3.5 billion on behalf of our clients. Bernstein Liebhard LLP is honored to once again be named to The National Law Journal's "Plaintiffs' Hot List," recognizing the top plaintiffs firms in the country. This year's nomination marks the thirteenth year the firm has been named to this prestigious annual list.
Bernstein Liebhard LLP 10 East 40th Street New York, New York 10016 800-511-5092